Capstone Investment Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-61,790
| Closed | -$232K | – | 1332 |
|
|
2024
Q1 | $232K | Buy |
61,790
+42,949
| +228% | +$161K | ﹤0.01% | 1127 |
|
|
2023
Q4 | $185K | Buy |
+18,841
| New | +$185K | ﹤0.01% | 867 |
|
|
2022
Q2 | – | Sell |
-10,498
| Closed | -$96K | – | 1079 |
|
|
2022
Q1 | $96K | Buy |
+10,498
| New | +$96K | ﹤0.01% | 786 |
|
|
2020
Q1 | – | Sell |
-205,337
| Closed | -$1.06M | – | 490 |
|
|
2019
Q4 | $1.06M | Sell |
205,337
-15,108
| -7% | -$77.6K | 0.01% | 240 |
|
|
2019
Q3 | $1.14M | Sell |
220,445
-231,785
| -51% | -$1.2M | 0.01% | 181 |
|
|
2019
Q2 | $2.74M | Buy |
452,230
+204,917
| +83% | +$1.24M | 0.02% | 139 |
|
|
2019
Q1 | $1.79M | Sell |
247,313
-370,579
| -60% | -$2.68M | 0.02% | 129 |
|
|
2018
Q4 | $4.57M | Buy |
+617,892
| New | +$4.57M | 0.06% | 78 |
|
|
2016
Q3 | – | Sell |
-18,500
| Closed | -$130K | – | 750 |
|
|
2016
Q2 | $130K | Buy |
+18,500
| New | +$130K | ﹤0.01% | 550 |
|